Catalent continues cell and gene therapy push with deal for Belgian CDMO
Catalent’s Belgian manufacturing foothold is widening, as the company moves to acquire yet another cell and gene therapy CDMO in the area. Catalent locked in...
Cell Therapy
Bristol Myers, hot off Breyanzi nod, plots new cell therapy factory in Massachusetts
Bristol Myers Squibb, freshly armed with an approval for its CAR-T lymphoma therapy Breyanzi, is making a major cell therapy manufacturing play. The company is...
Charles River jumps into cell and gene therapy manufacturing with $875M Cognate buy
Just a few weeks after Cognate BioServices moved to beef up its cell and gene therapy manufacturing, the company has attracted a buyer eager to...
Fujifilm continues CMDO expansion spree with $76M in funding for new Boston site
That didn’t take long. Fujifilm is laying plans for a new manufacturing facility in Watertown, Massachusetts—the second it’s announced in a little over a week....
With new CEO on board, Germany’s Vibalogics lays out $150M for Boston viral vector site
With the race for COVID-19 vaccines heating up and the cell and gene therapy market booming, contract manufacturers in the viral vector space are quickly...
Showa Denko’s Minaris plots $64.5M manufacturing expansion in Europe and Asia
Less than two months ago, Hitachi Chemicals’ regenerative medicines business adopted the name Minaris to boost brand recognition as a global cell and gene therapy CDMO. Fresh off...
Catalent continues big push into cell and gene therapies with Belgian facility buyout
New Jersey CDMO Catalent has made waves the past couple years in the bustling cell and gene therapy space with a series of big acquisitions....
DNA maker Touchlight adds Lonza manufacturing vet as it swings at COVID-19 vaccine, cell and gene therapy markets
With dozens of approvals expected in the coming years, the cell and gene therapy space has turned into a goldmine for contract manufacturers. But COVID-19...
Viral vector manufacturer Vibalogics adds CEO to lead expansion, COVID-19 response
In the bustling cell and gene therapy space, commercial manufacturing capacity will have a tough time keeping up with the potentially dozens of candidates hitting the...
Takeda unveils new Boston R&D manufacturing center for cell therapy pipeline push
Japanese drugmaker Takeda has trumpeted its plan in recent years to cut billions of dollars in costs and pivot around oncology and rare diseases. A...